A116 MP versus MPT in Elderly Myeloma Patients: The Final Outcome of the HOVON-49 Study

PW Wijermans; S Zweegman; M Van Marwijk Kooy; R Van der Griend; H Lokhorst; M Schaafsma; Y Van Norden; M Ammerlaan; S Wittebol; H Sinnegen; P Sonneveld

Journal Article

A116 MP versus MPT in Elderly Myeloma Patients: The Final Outcome of the HOVON-49 Study

Wijermans P
Zweegman S
Van Marwijk Kooy M
et al.

Clinical Lymphoma and Myeloma (2009) 9 S18-S19

DOI: 10.1016/s1557-9190(11)70466-8

N/ACitations

1Readers

Get full text

Cite

CITATION STYLE

APA

Wijermans, P., Zweegman, S., Van Marwijk Kooy, M., Van der Griend, R., Lokhorst, H., Schaafsma, M., … Sonneveld, P. (2009). A116 MP versus MPT in Elderly Myeloma Patients: The Final Outcome of the HOVON-49 Study. Clinical Lymphoma and Myeloma, 9, S18–S19. https://doi.org/10.1016/s1557-9190(11)70466-8

A116 MP versus MPT in Elderly Myeloma Patients: The Final Outcome of the HOVON-49 Study

Cite

Register to see more suggestions